Displaying 31 - 40 of 243
Alternative Name: Calrecticulin 3, Calsperin, Cancer/Testis Antigen 93, Calreticulin-2, CRT2, Testis Secretory Sperm-Binding Protein Li 226n, CMH19, CT93
Target
User: Male
Mode: No
Role in reproduction: Spermatogenesis
Project Stage: Target Validation
Alternative Name: Capronor Biodegradable Implant
Active Status: No
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: RTI International, NICHD
Project Stage: Phase II
Active Status: Yes
User: Male
Mode: No
Delivery Type: Oral
Developer: University of Rajasthan, India
Project Stage: Phase I
Target
Active Status: Yes
User: Female, Male
Mode: No
Developer: Hydra Biosciences, University of Minnesota, University of California at Berkeley, Harvard University, Dare BioScience Inc.
Role in reproduction: Sperm Function
Project Stage: Lead Optimization
Alternative Name: SILCS Diaphragm
Active Status: Yes
User: Female
Mode: No
Delivery Type: Barrier
Developer: PATH, CONRAD, SILCS, Inc., Kessel Marketing & Vertriebs GmbH
Project Stage: SRA/WHO PQ Approved
Alternative Name: Cyclin-dependent kinases (CDKs)
Target
Active Status: Yes
User: Male
Mode: Yes
Developer: University of Kansas Medical Center, University of Minnesota, Moffitt Cancer Center at University of South Florida
Project Stage: Target Identification
Active Status: Unknown
User: Female
Mode: Yes
Delivery Type: Subdermal
Developer: CEMAG
Project Stage: Pre-clinical
Alternative Name: Saheli; Ormeloxifene
Active Status: Yes
User: Female
Mode: No
Delivery Type: Oral
Developer: Central Drug Research Institute, India, HLL Lifecare Limited
Project Stage: Marketed
Active Status: No
User: Male
Mode: No
Delivery Type: Vas Deferens
Developer: National Research Institute for Family Planning in Beijing
Project Stage: Prototype Development
Active Status: No
User: Male
Mode: No
Delivery Type: Vas Deferens
Developer: National Research Institute for Family Planning in Beijing
Project Stage: Phase II
Pages
